Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter


FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled


Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

ASA Comments on CMS Rule Regarding 2014 Edition CEHRT

Tuesday, July 22, 2014

On July 21, the American Society of Anesthesiologists (ASA) offered general support to a CMS proposed rule that modifies Certified Electronic Health Record Technology (CEHRT) requirements for 2014 and requested a review of how physicians, including anesthesiologists, report electronic Clinical Quality Measures (CQMs). The ASA comment letter also reiterated the importance of the Hardship Exemption for anesthesiologists. The hardship exemption allows anesthesiologists to avoid the EHR program payment adjustment.

The proposed rule, applicable to practitioners participating the EHR Incentive Program, would allow providers who could not fully implement 2014 Edition CEHRT (because of delays in 2014 Edition availability) to continue to use 2011 Edition CEHRT or a combination of the 2011 and 2014 Editions for Stage 1 or Stage 2 meaningful use.  The proposed rule is valid for 2014 only. CMS has provided a tool for eligible professionals participating in the program to understand how the rule, if finalized, might affect their participation.

ASA also supported the provision for delaying meaningful use Stage 3 to 2017. In particular, ASA appreciated the intent of CMS and the Office of the National Coordinator for Health Information Technology (ONC) to analyze Stage 2 data in preparation for making Stage 3 criteria decisions. The proposed rule for Stage 3 meaningful use has not been released.

ASA also requested a critical evaluation of CQMs that physicians, including anesthesiologists, may report. CMS has sought opportunities in the past to align CQM reporting across both the EHR and Physician Quality Reporting System (PQRS) programs. However, since most CQMs reflect primary care practice and chronic care management, the streamlining of such measures often fails to address the underlying challenge for anesthesiologists to report specialty-specific measures. ASA asked CMS to explore additional pathways for implementing specialty-specific CQMs across both EHR and PQRS programs.

For more information, please visit the ASA webpage on EHRs or contact the ASA Department of Quality and Regulatory Affairs (QRA) at (202) 289-2222 or via e-mail at

« Back to Washington Alerts